I zipped off this quick podcast from my phone on Monday and put it on my secondary blog, which I run for scrappy stuff. People seemed to like it a bit so I’m reposting here. There’s more audio stuff coming, a bit of video too, and I’ll work out good feeds and iTunes stuff over the next couple of weeks. Cheery pip.
What do you do, as a campaigner for libel reform, when a litigious millionaire calls you a liar? This ethical quandary was presented to me last week when twitter account of Gillian McKeith – or to give her full medical title, “Gillian McKeith” – called my book “lies”. Read the rest of this entry »
This week the FDA voted not to ban GlaxoSmithKline’s diabetes drug rosiglitazone (brand name Avandia). Their vote has been reported as a victory for the company. I don’t think so: this saga tells an ugly story about our collective medical incompetence.
This week the food and nutrition pills industries are complaining. They like to make health claims about their products, which often turn out to be unsupported by the evidence. Regulating that mess would be tedious and long-winded, the kind of project enjoyed by the EU, and so the Nutrition and Health Claims Regulation was brought in during 2006. Since then, member states have submitted tens of thousands of health claims on behalf of manufacturers about cranberries, fish oil, and every magical ingredient you can think of. This week it turned out that 900 have been examined so far, of which 80% have unsurprisingly been rejected. Read the rest of this entry »